THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Sinopharm-CNBG and G42 joint venture Hayat Biotech supplies influenza vaccine to UAE

Official image for Sinopharm-CNBG and G42 joint venture Hayat Biotech supplies influenza vaccine to UAE
Official collaboration image · verified from the named source

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

A quadrivalent influenza vaccine developed by a Sinopharm CNBG subsidiary won a UAE purchase bid through Hayat Biotech, the CNBG-G42 joint venture, following UAE regulatory approval.

Current status
Official collaboration
Known availability
Started 2024-05-03; the official source does not state an end date.
Place
International, United Arab Emirates
Source checked
September 12, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.